Evidence map›Paper›PMID 36204230›Full record

ArticleFrontiers in pharmacology2022

Network pharmacology and experimental verification-based strategy to explore the underlying mechanism of Liu Jun An Wei formula in the treatment of gastrointestinal reactions caused by chemotherapy for colorectal cancer.

Gaobiao Li, Liying Liu, Yiran Yin, Mengmeng Wang, Lei Wang, Jianwei Dou, Hongwei Wu, Yufei Yang, Bin He

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in pharmacology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.6field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 7 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Integrative analysis ofFrontiers in pharmacology · 2026
    Article
  5. Article
  6. Article
  7. Annals of translational medicine · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 1 country.

Gaobiao LiXiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing, China.
Liying LiuDongzhimen Hospital, Beijing University of Chinese Medicine, Beijing, China.
Yiran YinXiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing, China.
Mengmeng WangXiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing, China.
Lei WangXiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing, China.
Jianwei DouSchool of Pharmacy, Xi'an Jiaotong University, Xi'an, Shaanxi, China.
Hongwei WuInstitute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing, China.
Yufei YangXiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing, China.
Bin HeXiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing, China.
Chinese Academy of Medical Sciences & Peking Union Medical College · CNXiyuan Hospital · CNBeijing University of Chinese Medicine · CNDongzhimen Hospital Affiliated to Beijing University of Chinese Medicine · CNXi'an Jiaotong University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

colorectal cancergastrointestinal reactionsintestinal organoidLiu Jun An Wei formula (LJAW)network pharmacologytarget identification

Identifiers

PMID36204230
PMCPMC9530632
OpenAlexW4296483084

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.